Is cancer dangerous to the immune system?

Ephraim J Fuchs, Polly Matzinger

Research output: Contribution to journalArticle

Abstract

The hypothesis of immunologic surveillance of neoplasia is predicated on the theory that the immune system is capable of discriminating self from foreign antigens, and that tumor-specific antigens are regarded by the immune system as nonself. We propose here an alternate view, that the immune system has evolved to detect danger by employing 'professional' antigen-presenting cells as sentinels of tissue distress. In this model, cancers do not appear dangerous to the immune system, so that the default response of T cells to tumors is to be turned off. We discuss the implications for immunotherapy of malignancy.

Original languageEnglish (US)
Pages (from-to)271-280
Number of pages10
JournalSeminars in Immunology
Volume8
Issue number5
DOIs
StatePublished - Oct 1996

Fingerprint

Immune System
Neoplasms
Immunologic Surveillance
Autoantigens
Neoplasm Antigens
Antigen-Presenting Cells
Immunotherapy
T-Lymphocytes

Keywords

  • Antigen-presenting cells
  • Immune surveillance
  • Immunologic tolerance
  • T lymphocytes
  • Tumor immunology

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases
  • Immunology

Cite this

Is cancer dangerous to the immune system? / Fuchs, Ephraim J; Matzinger, Polly.

In: Seminars in Immunology, Vol. 8, No. 5, 10.1996, p. 271-280.

Research output: Contribution to journalArticle

Fuchs, Ephraim J ; Matzinger, Polly. / Is cancer dangerous to the immune system?. In: Seminars in Immunology. 1996 ; Vol. 8, No. 5. pp. 271-280.
@article{cb7d45def19d4db59dbe3931de1e42ab,
title = "Is cancer dangerous to the immune system?",
abstract = "The hypothesis of immunologic surveillance of neoplasia is predicated on the theory that the immune system is capable of discriminating self from foreign antigens, and that tumor-specific antigens are regarded by the immune system as nonself. We propose here an alternate view, that the immune system has evolved to detect danger by employing 'professional' antigen-presenting cells as sentinels of tissue distress. In this model, cancers do not appear dangerous to the immune system, so that the default response of T cells to tumors is to be turned off. We discuss the implications for immunotherapy of malignancy.",
keywords = "Antigen-presenting cells, Immune surveillance, Immunologic tolerance, T lymphocytes, Tumor immunology",
author = "Fuchs, {Ephraim J} and Polly Matzinger",
year = "1996",
month = "10",
doi = "10.1006/smim.1996.0035",
language = "English (US)",
volume = "8",
pages = "271--280",
journal = "Seminars in Immunology",
issn = "1044-5323",
publisher = "Academic Press Inc.",
number = "5",

}

TY - JOUR

T1 - Is cancer dangerous to the immune system?

AU - Fuchs, Ephraim J

AU - Matzinger, Polly

PY - 1996/10

Y1 - 1996/10

N2 - The hypothesis of immunologic surveillance of neoplasia is predicated on the theory that the immune system is capable of discriminating self from foreign antigens, and that tumor-specific antigens are regarded by the immune system as nonself. We propose here an alternate view, that the immune system has evolved to detect danger by employing 'professional' antigen-presenting cells as sentinels of tissue distress. In this model, cancers do not appear dangerous to the immune system, so that the default response of T cells to tumors is to be turned off. We discuss the implications for immunotherapy of malignancy.

AB - The hypothesis of immunologic surveillance of neoplasia is predicated on the theory that the immune system is capable of discriminating self from foreign antigens, and that tumor-specific antigens are regarded by the immune system as nonself. We propose here an alternate view, that the immune system has evolved to detect danger by employing 'professional' antigen-presenting cells as sentinels of tissue distress. In this model, cancers do not appear dangerous to the immune system, so that the default response of T cells to tumors is to be turned off. We discuss the implications for immunotherapy of malignancy.

KW - Antigen-presenting cells

KW - Immune surveillance

KW - Immunologic tolerance

KW - T lymphocytes

KW - Tumor immunology

UR - http://www.scopus.com/inward/record.url?scp=0030272703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030272703&partnerID=8YFLogxK

U2 - 10.1006/smim.1996.0035

DO - 10.1006/smim.1996.0035

M3 - Article

C2 - 8956455

AN - SCOPUS:0030272703

VL - 8

SP - 271

EP - 280

JO - Seminars in Immunology

JF - Seminars in Immunology

SN - 1044-5323

IS - 5

ER -